Notal Vision
VA - ManassasBiotechnology
Focus: Notal Vision is a publicly traded medical device company specializing in home-based optical coherence tomography (OCT) and perimetry devices for age-related macular degeneration (AMD) monitoring. The company operates as a focused ophthalmology-specific device maker with a direct-to-patient monitoring technology platform.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Notal Vision
AI assessmentNot HiringNo open roles listed right now. Follow Notal Vision to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
34 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
ForeseeHome
Stable
Growth
Flagship home-based perimetry device for early CNV detection; appears in multiple clinical validation trials indicating ongoing development and market expansion efforts.
Notal Vision Home OCT / NOTAL-OCT V3.0
Help build intelligence for Notal Vision
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.